{"schema_version":"secwatch.filing_event.v1","accession":"0001599298-24-000004","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.758465+00:00","generated_at":"2026-06-07T04:40:55.938270+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Summit Therapeutics to present at J.P. Morgan Healthcare Conference on Jan 9, 2024","bullets":["Presentation on January 9, 2024 at 1:30 PM PT; includes update on ivonescimab development.","Robert W. Duggan (Chairman/CEO) and Dr. Maky Zanganeh (CEO/President) to present.","Audio webcast available live and archived on company website (www.smmttx.com)."],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-24-000004","json":"https://secwatch.observer/filing/0001599298-24-000004.json","markdown":"https://secwatch.observer/filing/0001599298-24-000004.md","text":"https://secwatch.observer/filing/0001599298-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000004/0001599298-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000004/smmt-20240103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:40:55.938270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}